Middle ear cholesteatomas (MEC) initially present with mild symptoms, which become more pronounced with increasing cyst size. An early stage MEC may manifest with foul-smelling otorrhea. Patients may feel an increased feeling of pressure in the affected ear, which can occasionally lead to painful sensations in or behind the ear. The pressure and exerted by the MEC can also be conducive to an inflammatory response including the formation of granulation tissue because of an infection (acute or chronic otitis media [1] [2]) and result in progressive hearing loss, in particular around the frequency of 2 kHz [3].

If left untreated, the growing MEC will likely perforate the tympanic membrane, damage the vicinal middle ear bone structure and also present with complications like chronic ear swelling, facial palsy [4], sometimes dizziness due to the development of a labyrinthine fistula, ossicular damage, meningitis, sigmoid sinus thrombosis or intracranial abscess [5] [6] [7].

Risk factors for MEC development are recurring middle ear infections, allergies, frequent exposure to cigarette smoke, eustachian tube malformations or cleft palate [8]. MECs do not have blood supply and administration of topical antibiotics will not ease otorrhea symptoms.

• Tinnitus

  Tinnitus and fullness of the ear Patients are usually asymptomatic but can present with ear fullness and tinnitus.[6].Tinnitus is ringing or humming of one or both ears without any stimulus. It is a manifestation of tinnitus.[3],[6]. [explainmedicine.com]

  […] and headacheC Vertigo. tinnitus hearing loss and headacheD Vertigo tinnitus and hearing loss 55) Motion sickness cannot be prevented by:A PromethazineB AstemizoleC HyoscineD Buclizine 56) Eustachian tube opens into middle ear cavity at which of the following [gradestack.com]

  SIGNS AND SYMPTOMS: Early symptoms of cholesteatoma include hearing loss, mucopurulent (brown/yellow) drainage from the ear, ear bleeding, ear pain, tinnitus and vertigo. [dallasear.com]

  Learn More About Topic Tinnitus Over 50 million Americans have experienced tinnitus, or ringing in ears, which is the perception of sound without an external source being present. [entnet.org]

• Otalgia

  The other patient, a 55-year-old man, was admitted to our hospital for a detailed examination because he had right otalgia and progressive headache. [ncbi.nlm.nih.gov]

  Otalgia Cholesteatoma itself is not often painful. But when it is associated with infection, it may cause pain.[2]. [explainmedicine.com]

  Case report A 40-year-old male, was admitted to ENT Department of the 20 Aout hospital, Ibn Rochd university hospital, with large mastoiditis of the right ear, otalgia, fever, severe headache and nausea. [annexpublishers.co]

  Vertiginous syndromes in diseases classified elsewhere H83 내이의 기타 질환 Other diseases of inner ear 귀의 기타 장애(H90-H95) Other disorders of ear H90 전음성 및 감각신경성 쳥력손실 Conductive and sensorineural hearing loss H91 기타 청력손실 Other hearing loss H92 귀통증 및 귀의 삼출액 Otalgia [rich-world.tistory.com]

• Hearing Impairment

  OBJECTIVE: Evaluate hearing impairment in acquired middle ear cholesteatoma and investigate audiometric differences between children and adults. STUDY DESIGN: Cross-sectional comparative study. SETTING: Tertiary hospital. [ncbi.nlm.nih.gov]

  He also had intermittent otorrhea, hearing impairment from right ear with mild dizziness for the past two years. The patient denied any history of diabetes mellitus, hypertension, or pulmonary tuberculosis. [annexpublishers.co]

  Thus, the sound is no longer transmitted adequately to the inner ear, resulting in a hearing impairment. Treatment If one wants to achieve complete healing of a cholesteatoma, the only option is surgery. [hear.com]

• Ear Discharge

  If a patient presents to a doctor with ear discharge and hearing loss, the doctor should consider cholesteatoma until the disease is definitely excluded. [en.wikipedia.org]

  discharge, tinnitus and headacheC Vertigo. tinnitus hearing loss and headacheD Vertigo tinnitus and hearing loss 55) Motion sickness cannot be prevented by:A PromethazineB AstemizoleC HyoscineD Buclizine 56) Eustachian tube opens into middle ear cavity [gradestack.com]

  Samples (swabs) of the ear discharge may also be taken. The discharge often contains a germ (bacterium) called Pseudomonas which is responsible for the smell. [patient.info]

• Hearing Problem

  After a while you may get hearing problems in that ear. If the cholesteatoma is left untreated it can spread into the balance centres of the inner ear, causing dizziness. [patient.info]

  Resulting hearing problems are due to conductive hearing loss Conduct : to channel, lead or convey from one point to another. [successforkidswithhearingloss.com]

• Dizziness

  Abstract Middle ear cholesteatoma caused by repeated ear infections over time, destroys the delicate middle ear bones and causes permanent hearing loss or dizziness. It may grow to involve the facial nerve causing facial paralysis. [ncbi.nlm.nih.gov]

  Erosion of the cholesteatoma into the inner ear can be recognized by dizziness induced by pressure, provoked by the " Valsalva " test, or dizziness induced by sound provoked by the "Tullio" test. These are very specific findings. [dizziness-and-balance.com]

  Symptoms of a cholesteatoma include: Persistent ear infection in one ear Pain or numbness in the ear or around the ear Drainage from the ear Dizziness or vertigo Diagnosis Diagnosing cholesteatoma requires careful examination supplemented by advanced [hopkinsmedicine.org]

  Headache and vertigo Disease may rarely causes vertigo.[1].Some patients may also present with dizziness and headache.[6]. [explainmedicine.com]

  This can cause nerve loss and deafness as well as severe imbalance and dizziness. The thin plate of bone that separates the roof of the ear from the brain can also be eroded by cholesteatomas. This exposes the covering of the brain. [medical-dictionary.thefreedictionary.com]

• Vertigo

  Headache and vertigo Disease may rarely causes vertigo.[1].Some patients may also present with dizziness and headache.[6]. [explainmedicine.com]

  […] ear discharge, tinnitus and headacheC Vertigo. tinnitus hearing loss and headacheD Vertigo tinnitus and hearing loss 55) Motion sickness cannot be prevented by:A PromethazineB AstemizoleC HyoscineD Buclizine 56) Eustachian tube opens into middle ear [gradestack.com]

  SIGNS AND SYMPTOMS: Early symptoms of cholesteatoma include hearing loss, mucopurulent (brown/yellow) drainage from the ear, ear bleeding, ear pain, tinnitus and vertigo. [dallasear.com]

  Symptoms of a cholesteatoma include: Persistent ear infection in one ear Pain or numbness in the ear or around the ear Drainage from the ear Dizziness or vertigo Diagnosis Diagnosing cholesteatoma requires careful examination supplemented by advanced [hopkinsmedicine.org]

  Review of systems questions includes subjective hearing loss, tinnitus, otorrhea, otalgia, ear pressure, and vertigo. Have you seen other doctors for this problem and have you had any imaging studies, if so where were they performed. [ncbi.nlm.nih.gov]

• Nystagmus

  If facial paralysis or a nystagmus (eye twitch, in the event of infection of the inner ear, specifically the balance organ) occurs, surgery is imperative. [hear.com]

  […] diagnosed to have acute otitis mediaC Xylitol is commonly used sweetener inhibits the growth of pneumococcal growthD Ventilation tube insertion the incidence by 50%. 100) 30 year female came to OPD with c/o feeling of giddiness with movements of head with nystagmus [gradestack.com]

MEC diagnosis relies on an otoscopic examination of the patient's ear as a first attempt to rationalize presented symptoms. Laboratory tests or histological investigations are usually not necessary, but may be ordered to corroborate diagnosis. Ear drainage may, however, be analyzed for potential middle ear infections, which can present as a complication of MEC growth, particularly if the tympanic membrane has been damaged. Histological findings of extracted MEC tissue specimens will yield typical squamous epithelial cell results indistinguishable from keratomas. Audiometric tests may also be taken into consideration in more complicated cases with significant hearing loss, especially before imminent surgery. Air and bone conduction as well as speech reception measured should be determined. In urgent cases presenting with severe complications, audiometry should be omitted in favor of an immediate surgical intervention [9].

The method of choice for a reliable diagnosis are computed tomography (CT) and nuclear magnetic resonance (MRI) scans. CT investigations will accurately resolve potential expansion of the aditus and the mastoid antrum or ossicle erosion as well as generic bone erosion in the middle ear structure and its vicinity, while MRI procedures will be able to localize the the MEC and assess its extension into the middle ear cavity. CT procedures may be inappropriate to distinguish between MECs and granulation tissues [9] [10] [11] [12].

The only effective means to treat MECs is their physical removal in the context of a surgical procedure. In case of a diagnosed inflammatory response as a complication MEC formation, prescription of topical antimicrobial agents is strongly advised prior to surgery. High pre-operative middle ear hygiene standards may slow down MEC growth.

Surgeons may have to decide between a canal wall-up (closed) and a canal wall-down (open) mastoidectomy. Canal wall-down operations usually provide the best long-term healing chances for patients. Wall-up procedures provide a better cosmetic prognosis for the patient at the cost of an increased risk of future MEC regrowth. After surgical removal, it is strongly recommended to schedule a tympanomastoidectomy procedure as a control measure within twelve months after the first intervention [13] [14].

Congenital MEC is often associated with a malfunction of the eustachian tube. Whenever such a malfunction is diagnosed or suspected, a canal wall-down procedure may provide a better prognosis, although an intact-canal technique has also been shown to provide satisfying healing chances in congenital MEC patients [15].

All mastoid air cells should be removed independent of the chosen technique. In case of ossicle damage, ossicle removal is imperative [15] and requires an ossicle reconstruction procedure. The tympanic membrane also needs to be reconstructed. Cartilage grafts or a meatoplasty may be required to recover a well-ventilated and structurally intact middle ear cavity.

In case of diagnosed hearing loss, use of hearing aids may be advisable.

Post-operative healing perspectives for patients are usually good, provided MECs were removed in an early stage. Patients may suffer from symptoms like temporary dizziness or distorted taste sensations in the immediate aftermath of the procedure. If the removed MEC was large, irreversible but moderate hearing loss, balance problems and vertigo may persist in rare cases [16].

A single MEC removal procedure need not be sufficient. MEC recurrence probability has been estimated to be around five percent in canal wall-down procedures, whereas the canal wall-up technique offers a MEC regrowth chance of twenty up to forty percent [17].

Severe intracranial complications like meningitis have become less fatal due to earlier recognition and more efficient surgical interventions.

Repeated middle ear infections and an impaired middle ear ventilation due to a malformed eustachian tube are hallmark culprits for the formation of MECs. If the eustachian tube does not allow for proper air circulation in the middle ear, a negative pressure in the middle ear may lead to a permanently distorted tympanic membrane, which is at an increased risk to develop a cyst, which can turn into MECs.

Congenital MECs have been rationalized with an entrapment of squamous epithelial cells within the temporal bone during embryogenesis. Typical locations for congenital MECs are the anterior mesotympanum or the perieustachian tube area [18]. Congenital MECs can also present behind intact tympanic membranes [19] [20] [21].

Acquired MEC cases can develop as a consequence of a direct lesion of the tympanic membrane or of a retraction of the tympanic membrane into the middle ear cavity, which typically leads to ossicular damage [22].

MEC development is also a possible complication of tympanostopy tube insertion procedures [23] [24].

The mean annual incidence of MEC has been estimated to be 9.2 per 100 000 (range 3.7-13.9) in industrialized countries. MECs are very rare in patients which present with an intact tympanic membrane and without a history of otitis media, accounting for less than 1% of diagnosed cases. Patients presenting with cleft palates are at an increased risk, as are patients with recurrent otitis media episodes. Men who are younger than 50 seem to be a risk group. MEC diagnosis does not correlate with social status [22].

There is strong and accumulating evidence that the origin of the squamous epithelial cells extracted from histological examinations is the tympanic membrane, not the middle ear epithelium, as shown from different protein and cytokeratin profiles [6] [25] [26].

MEC formation is caused by a complex and not yet fully disclosed imbalance of cytokines, growth factors and bacterial toxins conducive to a recurrent scheme of cell proliferation, keratinocyte differentiation and keratinocyte apoptosis. Cytokines have been implicated to be involved in osteoclast activation and maturation, which can lead to the degradation of the extracellular bone matrix and result in the observation of severe MEC complications [27] [28].

Congenital MECs cannot be prevented. Early treatment is thus a major factor to avoid severe complications. Acquired MECs can be quite efficiently prevented by swift and successful treatments of middle ear infections.

Animal studies have revealed that administration of vitamin A and Cortisporin may be effective in stalling MEC growth [29].

Long-term monitoring of the patient is imperative to prevent MEC recurrence.

Middle ear cholesteatomas are non-cancerous and initially present with mild symptoms and painless otorrhea but can have lead to severe consequences ranging from permanent moderate hearing loss to meniningitis or intracranial abscess. MEC cannot be cured with antimicrobial agents. The only efficient treatment requires the surgical removal within a mastoidectomy procedure. This intervention provides excellent healing chances with a very little chance of recurrence. Patients should be advised to have their middle ear regularly examined for regrowth.

Middle ear cholesteatomas are cysts in the middle ear that must be removed as soon as possible to avoid serious complications like permanent hearing loss or brain-related diseases. Immediate consultation of a medical professional is advisable, if foul-smelling ear drainage occurs concomitant with an increased feeling of pressure in the ear. Doctors will first check for possible infections, may prescribe antibiotics, and schedule a surgical removal procedure. Regular control examinations are necessary to avoid cholesteatoma regrowth.

1. Harker LA. Cholesteatoma an evidence study. In: McCabe BF, Sade J, Abramson M, eds. Cholesteatoma First International Conference. Birmingham, UK: Aesculapius Publications; 1977:308–309.
2. Tos M. Incidence, etiology and pathogenesis of cholesteatoma in children. Adv Otorhinolaryngol. 1988; 40:110–117.
3. Luntz M, Yehudai N, Haifler M, Sigal G, Most T. Risk factors for sensorineural hearing loss in chronic otitis media. Acta Otolaryngol. 2013; 133(11):1173-1180.
4. Bagger-Sjöbäck D, Phelps PD. Cholesteatoma with extension to the cochlea. Am J Otol. 1985; 6(4):338–343.
5. Chole RA. Cholesteatoma conference summary. In: Nakano Y, ed. Cholesteatoma and Mastoid Surgery the Fourth International Conference. Amsterdam, NL: Kugler Publications; 1992:835–840.
6. Yamamoto-Fukuda T, Hishikawa Y, Shibata Y, Kobayashi T, Takahashi H, Koji T. Pathogenesis of Middle Ear Cholesteatoma A New Model of Experimentally Induced Cholesteatoma in Mongolian Gerbils. Am J Pathol. 2010; 176(6): 2602–2606.
7. Manolidis S, Kutz JW Jr. Diagnosis and management of lateral sinus thrombosis. Otol Neurotol. 2005; 26(5):1045-1051.
8. Djurhuus BD, Skytthe A, Faber CE, Christensen K. Cholesteatoma risk in 8,593 orofacial cleft cases and 6,989 siblings: A nationwide study. Laryngoscope. 2015; 125(5):1225-1229.
9. Gaurano JL, Joharjy IA. Middle ear cholesteatoma: characteristic CT findings in 64 patients. Ann Saudi Med. 2004; 24(6):442-447.
10. Muzaffar J, Metcalfe C, Colley S, Coulson C. Diffusion-weighted magnetic resonance imaging for residual and recurrent cholesteatoma: a systematic review and meta-analysis. Clin Otolaryngol. 2017; 42(3):536-543.
11. Yamashita K, Hiwatashi A, Togao O, et al. High-resolution three-dimensional diffusion-weighted MRI/CT image data fusion for cholesteatoma surgical planning: a feasibility study. Eur Arch Otorhinolaryngol. 2015; 272(12):3821-3824.
12. Locketz GD, Li PM, Fischbein NJ, Holdsworth SJ, Blevins NH. Fusion of Computed Tomography and PROPELLER Diffusion-Weighted Magnetic Resonance Imaging for the Detection and Localization of Middle Ear Cholesteatoma. JAMA Otolaryngol Head Neck Surg. 2016; 142(10):947-953.
13. Dawes PJ, Leaper M. Paediatric small cavity mastoid surgery: second look tympanotomy. Int J Pediatr Otorhinolaryngol. 2004; 68(2):143-148.
14. Prinsley P. An audit of 'dead ear' after ear surgery. J Laryngol Otol. 2013; 127(12): 1177-1183.
15. Jindal M, Riskalla A, Jiang D, Connor S, O'Connor AF. A systematic review of diffusion-weighted magnetic resonance imaging in the assessment of postoperative cholesteatoma. Otol Neurotol. 2011; 32(8):1243-1249.
16. Rosito LS, Netto LS, Teixeira AR, Costa SS. Sensorineural Hearing Loss in Cholesteatoma. Otol Neurotol. 2016; 37(3):214-217.
17. Roland PS, Meyerhoff WL. Open-cavity tympanomastoidectomy. Otolaryngol Clin North Am. 1999; 32(3):525-546.
18. Potsic WP, Korman SB, Samadi DS, Wetmore RF. Congenital cholesteatoma: 20 years' experience at The Children's Hospital of Philadelphia. Otolaryngol Head Neck Surg. 2002; 126(4):409-414.
19. De la Cruz A, Fayad JN. Detection and management of childhood cholesteatoma. Pediatr Ann. 1999; 28(6):370-373.
20. Lim HW, Yoon TH, Kang WS. Congenital cholesteatoma: clinical features and growth patterns. Am J Otolaryngol. 2012; 33(5):538-542.
21. Stapleton AL, Egloff AM, Yellon RF. Congenital cholesteatoma: predictors for residual disease and hearing outcomes. Arch Otolaryngol Head Neck Surg. 2012; 138(3):280-285.
22. Kemppainen HO, Puhakka HJ, Laippala PJ, Sipilä MM, Manninen MP, Karma PH. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol. 1999; 119(5):568-572.
23. Golz A, Goldenberg D, Netzer A, et al. Cholesteatomas associated with ventilation tube insertion. Arch Otolaryngol Head Neck Surg. 1999; 125(7):754-757.
24. Drahy A, De Barros A, Lerosey Y, Choussy O, Dehesdin D, Marie JP. Acquired cholesteatoma in children: Strategies and medium-term results. Eur Ann Otorhinolaryngol Head Neck Dis. 2012; 129(5):225-229.
25. Olszewska E, Sudhoff H. Comparative cytokeratin distribution patterns in cholesteatoma epithelium. Histol Histopathol. 2007; 22(1):37–42.
26. Xu Y, Tao ZZ, Hua QQ, Wang XX, Xiao BK. Expression and activation of nuclear factor-kappaB in middle ear cholesteatoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2006; 41(6):455–459.
27. Juhn SK, Jung MK, Hoffman MD, et al. The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin Exp Otorhinolaryngol. 2008; 1(3):117–138.
28. Maniu A, Harabagiu O, Perde Schrepler M, Cătană A, Fănuţă B, Mogoantă CA. Molecular biology of cholesteatoma. Rom J Morphol Embryol. 2014; 55(1):7-13.
29. Nageris BI, Grushko I, Feinmesser R. Cholesteatoma prevention by local treatment with vitamin A. Otol Neurotol. 2001; 22(5):576-578.